SubscribeLogin
Inside FMCG image

News from Inside FMCG

We’ve assigned a media bias rating of to Inside FMCG. You can read more about our methodology here.

Information about Inside FMCG

Where is Inside FMCG located?Inside FMCG's Website

Media Bias Ratings

Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.

Factuality

Learn more about  Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about  Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Inside FMCG News

Possible takeover of Hershey: What's the impact? What could prevent a merger?
Stock Markets · Lancaster

Possible takeover of Hershey: What's the impact? What could prevent a merger?

43% Right coverage: 14 sources
After Mondelez reportedly approached the Hershey Company about an acquisition, we're taking a closer look at the potential economic impact and what could prevent a merger.See the Story
Lawsuit accuses major food companies of marketing ‘addictive’ food to kids
Diabetes

Lawsuit accuses major food companies of marketing ‘addictive’ food to kids

37% Center coverage: 11 sources
By Reuters (Reuters) — Major food companies, including Kraft Heinz, Mondelez and Coca-Cola, were hit with a new lawsuit in the US on Tuesday accusing them of designing and marketing “ultra-processed” foods to be addictive to children, causing chronic disease. The lawsuit was filed in the Philadelphia Court of Common Pleas by Bryce Martinez, a Pennsylvania resident who alleges he developed type 2 diabetes and non-alcoholic fatty liver disease, di…See the Story
Merck reaches weight-loss drug deal worth up to $2 billion with China-based Hansoh
Nestlé

Merck reaches weight-loss drug deal worth up to $2 billion with China-based Hansoh

67% Center coverage: 9 sources
Merck announced a weight loss drug deal Wednesday with China-based Hansoh worth up to $2 billion for the pill code-named HS-10535. It includes a $112 million licensing rights payment for global sales outside China.See the Story

Latest News Stories

You've scrolled to the bottom of the feed, there are no more stories.
Trending Topics
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc
News
For You
Search
BlindspotLocal